Literature DB >> 19513133

Progressive Multifocal Leukoencephalopathy in AIDS: Proton MR Spectroscopy Patterns of Asynchronous Lesions Confirmed by Serial Diffusion-Weighted Imaging and Apparent Diffusion Coefficient Mapping.

Jung Han Yoon1, Oh Young Bang, Ho Sung Kim.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a rare disease that occurs mainly in immunocompromised patients. Despite the progressive nature of the disease, the changes on MRI during the disease course - which may help in monitoring the disease process - have seldom been reported. Here we describe a patient with polymerase-chain-reaction-proven PML examined using serial diffusion-weighted imaging (DWI) and apparent-diffusion-coefficient mapping. Magnetic resonance spectroscopy (MRS) revealed that the demyelinating process was more active without significant neuronal loss at the newer and advancing edge of a lesion than in the older central part of the lesion. This case shows that MRI findings such as DWI and MRS may improve the diagnosis and the understanding of the pathophysiology of PML.

Entities:  

Keywords:  AIDS; Diffusion-weighted imaging; Progressive multifocal leukoencephalopathy; Proton magnetic resonance spectroscopy

Year:  2007        PMID: 19513133      PMCID: PMC2686949          DOI: 10.3988/jcn.2007.3.4.200

Source DB:  PubMed          Journal:  J Clin Neurol        ISSN: 1738-6586            Impact factor:   3.077


  10 in total

1.  Lesion extension detected by diffusion-weighted magnetic resonance imaging in progressive multifocal leukoencephalopathy.

Authors:  K Ohta; K Obara; M Sakauchi; K Obara; H Takane; Y Yogo
Journal:  J Neurol       Date:  2001-09       Impact factor: 4.849

2.  Progressive multifocal leukoencephalopathy.

Authors:  R D Henderson; M G Smith; P Mowat; S J Read
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

3.  Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

Authors:  Joseph R Berger; Igor J Koralnik
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

4.  Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.

Authors:  B K Kleinschmidt-DeMasters; Kenneth L Tyler
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

5.  Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI.

Authors:  I Mader; U Herrlinger; U Klose; F Schmidt; W Küker
Journal:  Neuroradiology       Date:  2003-08-27       Impact factor: 2.804

6.  Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy.

Authors:  L Chang; T Ernst; C Tornatore; H Aronow; R Melchor; I Walot; E Singer; M Cornford
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

7.  Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.

Authors:  I L Simone; F Federico; C Tortorella; C F Andreula; G B Zimatore; P Giannini; G Angarano; V Lucivero; P Picciola; D Carrara; A Bellacosa; P Livrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

8.  Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection.

Authors:  I D Wilkinson; R F Miller; K A Miszkiel; M N Paley; M A Hall-Craggs; T Baldeweg; I G Williams; S Carter; S P Newman; B E Kendall; J Catalan; R J Chinn; M J Harrison
Journal:  AIDS       Date:  1997-03       Impact factor: 4.177

9.  Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations.

Authors:  M Bergui; G B Bradac; K K Oguz; A Boghi; C Geda; G Gatti; D Schiffer
Journal:  Neuroradiology       Date:  2003-10-31       Impact factor: 2.804

10.  Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS.

Authors:  A Iranzo; A Moreno; J Pujol; J Martí-Fàbregas; P Domingo; J Molet; J Ris; J Cadafalch
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

  10 in total
  11 in total

Review 1.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

2.  Proton MR spectroscopy in a 1T open MR imaging system.

Authors:  C G Filippi; T Pace; T G Perkins; J B Murdoch; T Andrews
Journal:  AJNR Am J Neuroradiol       Date:  2010-12-16       Impact factor: 3.825

Review 3.  Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.

Authors:  Linda Chang; Sody M Munsaka; Stephanie Kraft-Terry; Thomas Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-12       Impact factor: 4.147

4.  A prominent lactate peak as a potential key magnetic resonance spectroscopy (MRS) feature of progressive multifocal leukoencephalopathy (PML): Spectrum pattern observed in three patients.

Authors:  Duško Kozić; Mladen Bjelan; Jasmina Boban; Jelena Ostojić; Vesna Turkulov; Aleksandar Todorović; Slobodanka Lemajić-Komazec; Snežana Brkić
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

5.  Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T.

Authors:  Matthew S Davitz; William E Wu; Brian J Soher; James S Babb; Ivan I Kirov; Jeffrey Huang; Girish Fatterpekar; Oded Gonen
Journal:  Magn Reson Imaging       Date:  2016-08-28       Impact factor: 2.546

Review 6.  Posterior reversible encephalopathy syndrome in children with kidney diseases.

Authors:  Kenji Ishikura; Yuko Hamasaki; Tomoyuki Sakai; Hiroshi Hataya; Robert H Mak; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

7.  Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection.

Authors:  Daniel S Bucy; Mark S Brown; Helle Bielefeldt-Ohmann; Jesse Thompson; Annette M Bachand; Michelle Morges; John H Elder; Sue Vandewoude; Susan L Kraft
Journal:  J Neurovirol       Date:  2011-07-23       Impact factor: 2.643

8.  Global brain metabolic quantification with whole-head proton MRS at 3 T.

Authors:  Ivan I Kirov; William E Wu; Brian J Soher; Matthew S Davitz; Jeffrey H Huang; James S Babb; Mariana Lazar; Girish Fatterpekar; Oded Gonen
Journal:  NMR Biomed       Date:  2017-07-05       Impact factor: 4.044

Review 9.  Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities.

Authors:  Justin M Honce; Lidia Nagae; Eric Nyberg
Journal:  Mult Scler Int       Date:  2015-09-21

10.  Stroke mimicking encephalopathy as an initial manifestation of diffuse large B-cell lymphoma.

Authors:  Jeong-Min Kim; Keun-Hwa Jung; Soon-Tae Lee; Hee-Kwon Park; Kon Chu; Jae-Kyu Roh
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.